Abstract
We undertook an independent national survey of psychiatrists' treatment preferences should they become mentally ill. The response rate was 59% from 921 individuals. For psychosis, atypical antipsychotics were generally favoured with risperidone receiving most votes. Psychotherapy and antidepressants were both endorsed as treatments for mild-tomoderate depression, and citalopram, fluoxetine and venlafaxine were the three preferred antidepressants. ECT received the backing of a large majority of psychiatrists, particularly for severe mood disorder.
Get full access to this article
View all access options for this article.